deducted by an allowance for doubtful account of Baht 0.03 million, resulted in the record of the net profit of the Company and its subsidiary for the year 2017 of Baht 12.52 million, increasing by Baht
products at competitive prices and higher export value. Gross margin were Baht 5.09 million or 11.33 % in 2017 increasing from Baht 1.72 million or 8.90% for the same period in 2016. On June 15, 2016, the
420,284,565.87 Baht or 37.62%. This resulted from the amount of orders increased. The cost of sales in year 2018 was 1,349,555,652.00 Baht, representing 87.77% of total sales. The reasons were the increasing of
medical treatments when compared to income from medical treatments went up 1.94% from CMR a subsidiary went up 3.73% due to expending employment increase and depreciation of building is increasing. The cost
lower other incomes; consequently, loss was Baht 2.30 million higher in 2018 even the gross margin was better. Gross margin were Baht 6.13 million or 17.97 % in 2018 increasing from Baht 5.09 million or
, the Board of Directors have approved the increasing of SBLC facility amount via email on 28 March 2019 and then the Company had entered into the amendment of credit facility agreement on 1 April 2019
increased 7.31%, it increased in portion of increasing revenue but expenses were at the same level as last year and finance cost decreased 14.18% from last year from liability decreased too. The Company had
which decreased from that of the same quarter last year totaling 53.88 million Baht or 19.51% due to a decrease in sales. This resulted in gross profit of 16.09%, increasing by 2.43% from 13.66% in the
services, the selling and servicing expenses and the administrative expenses of the Company and its subsidiary for the second quarter of the year 2019 was Baht 26.23 million, increasing by Baht 2.84 million
Expenses For 6 month period of 2019, such expenses are THB 63.78 million which increases from that of year 2018 by THB 18.41 million. An increasing of 40.58 percent compared to last year PAE (Thailand